Redmile Group as of March 31, 2019
Portfolio Holdings for Redmile Group
Redmile Group holds 82 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 7.8 | $268M | 11M | 24.38 | |
| Amicus Therapeutics (FOLD) | 7.8 | $267M | 20M | 13.60 | |
| Fate Therapeutics (FATE) | 5.3 | $182M | 10M | 17.57 | |
| Atara Biotherapeutics | 5.2 | $178M | 4.5M | 39.75 | |
| Argenx Se (ARGX) | 3.7 | $127M | 1.0M | 124.84 | |
| Clovis Oncology | 3.3 | $113M | 4.6M | 24.82 | |
| Alder Biopharmaceuticals | 3.3 | $113M | 8.2M | 13.65 | |
| Wave Life Sciences (WVE) | 3.2 | $110M | 2.8M | 38.85 | |
| Audentes Therapeutics | 3.1 | $107M | 2.7M | 39.02 | |
| Epizyme | 2.8 | $95M | 7.7M | 12.39 | |
| Xencor (XNCR) | 2.8 | $94M | 3.0M | 31.06 | |
| Wright Medical Group Nv | 2.6 | $90M | 2.9M | 31.45 | |
| Inflarx Nv (IFRX) | 2.4 | $83M | 2.2M | 37.79 | |
| Regenxbio Inc equity us cm (RGNX) | 2.4 | $81M | 1.4M | 57.31 | |
| Uniqure Nv (QURE) | 2.3 | $78M | 1.3M | 59.65 | |
| Bristol Myers Squibb (BMY) | 2.2 | $76M | 1.6M | 47.71 | |
| eHealth (EHTH) | 2.2 | $76M | 1.2M | 62.34 | |
| Allakos | 2.2 | $74M | 1.8M | 40.50 | |
| Livanova Plc Ord (LIVN) | 1.7 | $57M | 583k | 97.25 | |
| Tandem Diabetes Care (TNDM) | 1.6 | $54M | 856k | 63.50 | |
| Celgene Corporation | 1.5 | $51M | 536k | 94.34 | |
| Anthem (ELV) | 1.5 | $51M | 177k | 286.98 | |
| Teva Pharmaceutical Industries (TEVA) | 1.4 | $49M | 3.1M | 15.68 | |
| Penumbra (PEN) | 1.4 | $48M | 323k | 147.01 | |
| Align Technology (ALGN) | 1.2 | $41M | 143k | 284.33 | |
| Biogen Idec (BIIB) | 1.1 | $39M | 165k | 236.38 | |
| Cymabay Therapeutics | 1.1 | $39M | 2.9M | 13.28 | |
| Jazz Pharmaceuticals (JAZZ) | 1.1 | $39M | 270k | 142.95 | |
| Scholar Rock Hldg Corp (SRRK) | 1.1 | $39M | 2.1M | 18.79 | |
| Deciphera Pharmaceuticals | 1.1 | $38M | 1.6M | 23.21 | |
| Anaptysbio Inc Common (ANAB) | 1.1 | $36M | 497k | 73.05 | |
| ImmunoGen | 1.0 | $35M | 13M | 2.71 | |
| Oxford Immunotec Global | 1.0 | $35M | 2.0M | 17.23 | |
| Replimune Group (REPL) | 1.0 | $34M | 2.2M | 15.22 | |
| Array Biopharma Inc bond | 1.0 | $33M | 19M | 1.75 | |
| UnitedHealth (UNH) | 1.0 | $33M | 133k | 247.26 | |
| Invitae (NVTAQ) | 0.9 | $32M | 1.4M | 23.42 | |
| Gritstone Oncology Ord (GRTSQ) | 0.9 | $31M | 2.4M | 13.30 | |
| Xeris Pharmaceuticals | 0.9 | $30M | 3.0M | 10.04 | |
| Tcr2 Therapeutics Inc cs | 0.8 | $29M | 1.8M | 15.87 | |
| Glycomimetics | 0.7 | $25M | 2.0M | 12.46 | |
| Teladoc (TDOC) | 0.7 | $25M | 440k | 55.60 | |
| Alder Biopharmaceuticals Inc convertible security | 0.7 | $24M | 25M | 0.95 | |
| Morphosys (MOR) | 0.6 | $20M | 894k | 22.70 | |
| Eidos Therapeutics | 0.6 | $20M | 852k | 23.45 | |
| Heska Corporation | 0.6 | $19M | 226k | 85.12 | |
| Pra Health Sciences | 0.6 | $19M | 174k | 110.29 | |
| Tricida | 0.6 | $19M | 490k | 38.62 | |
| Vapotherm | 0.6 | $19M | 1.0M | 18.72 | |
| Syros Pharmaceuticals | 0.4 | $15M | 1.6M | 9.14 | |
| Axonics Modulation Technolog (AXNX) | 0.4 | $14M | 599k | 23.95 | |
| ICU Medical, Incorporated (ICUI) | 0.4 | $12M | 52k | 239.32 | |
| Krystal Biotech (KRYS) | 0.3 | $11M | 325k | 32.90 | |
| Odonate Therapeutics Ord | 0.3 | $11M | 478k | 22.11 | |
| Si-bone (SIBN) | 0.3 | $10M | 539k | 18.84 | |
| Shockwave Med | 0.3 | $10M | 300k | 33.47 | |
| Global Blood Therapeutics In | 0.3 | $8.9M | 168k | 52.93 | |
| Logicbio Therapeutics | 0.3 | $9.0M | 910k | 9.88 | |
| AtriCure (ATRC) | 0.2 | $8.7M | 325k | 26.79 | |
| Chimerix (CMRX) | 0.2 | $7.4M | 3.5M | 2.10 | |
| Beigene (ONC) | 0.2 | $5.3M | 40k | 132.00 | |
| Gossamer Bio (GOSS) | 0.2 | $5.4M | 250k | 21.67 | |
| Establishment Labs Holdings Ord (ESTA) | 0.1 | $3.4M | 142k | 24.04 | |
| Arvinas Ord (ARVN) | 0.1 | $2.2M | 151k | 14.76 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $2.1M | 323k | 6.50 | |
| Jounce Therapeutics | 0.1 | $1.6M | 255k | 6.20 | |
| Ovid Therapeutics (OVID) | 0.0 | $1.3M | 738k | 1.77 | |
| Avedro | 0.0 | $1.5M | 125k | 12.27 | |
| Endologix | 0.0 | $521k | 79k | 6.62 | |
| LHC | 0.0 | $240k | 2.2k | 110.80 | |
| Gw Pharmaceuticals Plc ads | 0.0 | $475k | 2.8k | 168.44 | |
| Flexion Therapeutics | 0.0 | $270k | 22k | 12.48 | |
| Sage Therapeutics (SAGE) | 0.0 | $231k | 1.5k | 159.31 | |
| Vericel (VCEL) | 0.0 | $293k | 17k | 17.52 | |
| Nevro (NVRO) | 0.0 | $213k | 3.4k | 62.65 | |
| Myokardia | 0.0 | $325k | 6.3k | 51.98 | |
| Surgery Partners (SGRY) | 0.0 | $179k | 16k | 11.26 | |
| Cigna Corp (CI) | 0.0 | $265k | 1.6k | 160.80 | |
| Castlight Health | 0.0 | $38k | 10k | 3.71 | |
| Viking Therapeutics (VKTX) | 0.0 | $162k | 16k | 9.96 | |
| Aclaris Therapeutics (ACRS) | 0.0 | $68k | 11k | 6.01 | |
| Adverum Biotechnologies | 0.0 | $117k | 22k | 5.26 |
